Quebec court approves class action alleging opioid makers misled users about risks
A Quebec Superior Court judge has authorized a class-action lawsuit against 16 pharmaceutical companies that are alleged to have misled consumers about the efficacy and dangers of opioid medications.
The suit alleges the companies knew how addictive the drugs were but deliberately misrepresented those risks, leading users to become dependent.
"Traditionally, opioids were used in a very limited way medically," said Margo Siminovitch, one of the lawyers behind the lawsuit. "They were used for palliative care, for example, end of life, cancer treatment, or for acute pain post surgery. And then in the mid-1990s a new narrative emerged."
That new narrative involved pharmaceutical companies promoting the use of opioids as safe for a wide range of chronic pain conditions, ranging from headaches, to back pain and rheumatoid arthritis, she said in an interview Tuesday. "Doctors were told that if they didn't promote opioids and use them for their patients, they were doing their patients a disservice, and it just took off and became a huge industry."
Siminovitch said the lawsuit's representative plaintiff, Jean-Francois Bourassa, has a typical story.
Bourassa, who owned a roofing company, was prescribed opioids after he fell on the job in 2005 and suffered multiple fractures. Over the next decade, he was prescribed a range of opioids but says he was never warned by a doctor or pharmacist about any risks, according to Justice Gary D.D. Morrison's April 10 decision authorizing the class action.
By 2012, Morrison said, Bourassa was being prescribed the "maximum dose," but over the following years, the medication stopped having any effect. In 2017, he sought medical treatment for opioid addiction; it was at that time he learned about the dangers of the drugs.
Bourassa was diagnosed with severe opioid use disorder, and completed treatment for his addiction at a Montreal hospital. Yet after he left the treatment program, he received another opioid prescription from his doctor, at a lower dose than before; as a result, he was readmitted into a drug rehab program in 2018.
In court, Bourassa described his experience with opioids as "hell on Earth."
The class action includes everyone in Quebec who was prescribed opioid medications made by the 16 defendant pharmaceutical companies between 1996 and the present, and who was subsequently diagnosed with opioid use disorder.
Opioids that are not included in the lawsuit are OxyContin and OxyNEO, which were the subject of a separate national class-action lawsuit that has since been settled, and those that were exclusively used in hospitals. Several companies named when the suit was first proposed but that had limited activities in Quebec have already settled.
Siminovitch said she doesn't know how many people may be included in the class-action lawsuit. Around 15 per cent of Quebec residents are prescribed opioids every year, she said, adding that somewhere between five per cent and 10 per cent of opioid users become dependent or addicted.
The pharmaceutical companies named in the suit argued against allowing the class action to proceed. They said the suit treated all opioids as if they were the same, that it provided no evidence that all opioid medications are addictive, that the companies did not misrepresent their drugs and that the proposed suit included firms whose drugs the representative plaintiff never consumed.
In an emailed statement, Sanofi Canada said the decision is "purely procedural."
"This decision does not in any way relate to Sanofi's liability which is denied. Sanofi will continue to defend this matter," the company said, declining to comment further.
Sandoz Canada said it's committed to conducting business with integrity. "We believe that these claims are without merit and will vigorously contest them," the company said in an emailed statement.
Teva Canada said it "supports the safe and appropriate usage of opioid medications under the supervision of health-care professionals" but declined to comment further, while Pfizer declined to comment.
None of the other companies named in the suit responded to requests for comment from The Canadian Press. They are: Abbott Laboratories, Apotex, Bristol-Myers Squibb Canada, Ethypharm, Janssen, Labratoire Atlas, Labratoire Riva, Labratoire Trianon, Pharmascience, Pro Doc, Purdue Pharma and Sun Pharma Canada.
Siminovitch said she and her colleagues are waiting to see whether the defendants will seek permission to appeal the authorization. She said she hopes some will settle, but added that she and her colleagues are prepared to go to trial.
The suit seeks $30,000 in damages for each member of the class, plus additional damages to be determined on an individual basis, as well as a total of$25 million in punitive damages.
The Quebec government has joined a separate proposed class-action lawsuit brought by the government of British Columbia against dozens of opioid makers. That suit seeks billions of dollars for heath-care costs related to the opioid crisis.
-This report by The Canadian Press was first published April 16, 2024.
CTVNews.ca Top Stories
Blaine Higgs 'furious' over sexual education presentation
New Brunswick Premier Blaine Higgs has shared his anger on social media over a presentation in at least four high schools.
This type of screen time has the worst effect on kids: experts
According to some experts, there is one type of screen time that is continuously excessive, and it's having a severe effect on our children.
Grayson Murray's parents say the two-time PGA Tour winner died of suicide
Grayson Murray's parents said Sunday their 30-year-old son took his own life, just one day after he withdrew from a PGA Tour event.
Some birds may use 'mental time travel,' study finds
Real quick — what did you have for lunch yesterday? Were you with anyone? Where were you? Can you picture the scene? The ability to remember things that happened to you in the past, especially to go back and recall little incidental details, is a hallmark of what psychologists call episodic memory — and new research indicates that it’s an ability humans may share with birds called Eurasian jays.
Trump confronts repeated boos during raucous Libertarian convention speech
Donald Trump was booed repeatedly while addressing Saturday night’s Libertarian Party National Convention.
Driver, 18, gets $3,000 ticket, 32 demerit points after speeding on Laval boulevard
A young driver received a hefty fine from Laval police after they say he was driving nearly 100 km/h over the posted speed limit.
Indianapolis 500 delayed as strong storm forces fans to evacuate Indianapolis Motor Speedway
The start of the Indianapolis 500 was delayed as a strong storm pushed through the area Sunday, forcing Indianapolis Motor Speedway officials to evacuate about 125,000 fans who had already arrived for "The Greatest Spectacle in Racing."
Hamas rocket attack from Gaza sets off air raid sirens in Tel Aviv for the first time in months
Hamas fired a barrage of rockets from Gaza that set off air raid sirens as far away as Tel Aviv for the first time in months on Sunday in a show of resilience more than seven months into Israel's massive air, sea and ground offensive.
At least 13 dead in Texas, Oklahoma and Arkansas after severe weather roars across region
Powerful storms killed at least 13 people and left a wide trail of destruction Sunday across Texas, Oklahoma and Arkansas after obliterating homes and destroying a truck stop where dozens sought shelter in a restroom during the latest deadly weather to strike the central U.S.